It’s the Thought that Counts
Ophthalmic Product Development Insights
The Hows and Whys of Pharmacokinetics
Simple attributes, such as how much drug can reach its target
and how long it stays there, make a big difference in outcomes.
RISC and Reward with Inhibitory RNAs
A new understanding of ribonucleic acid’s activity in cells may
lead to breakthroughs in ophthalmic treatment.
The Secrets of Ocular Microbiomes
The placid ocular surface is actually teeming with life that might
hold the secret to treating ophthalmic disease.
Identifying and Filling the Unmet Need
Ophthalmic Product Development Insights
Quarterly Ora Newsletter - May 1, 2015
Customer Success Stories: Celebrating Your Big Wins in 2014-2015
Hopes and Hurdles for Stem Cell Therapy
The exciting world of stem cell therapy is the cutting edge of
medical research. Here’s how it intersects with ophthalmology.
Putting Your Contacts to Work
Attempts to engineer contact lenses that also elute therapeutic drugs face hurdles in both the world of lenses and of drugs.
The Scientist-Entrepreneur as CEO
Scientist-entrepreneurs often feel as if nobody knows their product better than they do.